SEC Comment Letter for Novo Integrated Sciences, Inc. (NVOS) (CIK 0001138978) — Sep 14, 2022
Novo Integrated Sciences, Inc. (NVOS) (CIK 0001138978)
Date: Sept. 14, 2022 · CIK: 0001138978 · Accession: 0000000000-22-010061
AI Filing Summary & Sentiment
File numbers found in text: 333-267401
Show Raw Text
United States securities and exchange commission logo
September 14, 2022
Robert Mattacchione
Chief Executive Officer
Novo Integrated Sciences, Inc.
11120 NE 2nd Street, Suite 100
Bellevue, WA 98004
Re:Novo Integrated Sciences, Inc.
Registration Statement on Form S-1
Filed September 13, 2022
File No. 333-267401
Dear Mr. Mattacchione:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rule 461 regarding requests for acceleration. We remind you that the
company and its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeff Kauten, Staff Attorney, at (202) 551-3447, or in his absence, Josh
Shainess, Legal Branch Chief, at (202) 551-7951, with any questions. If you require further
assistance, please contact Larry Spirgel, Office Chief, at (202) 551-3815.
Sincerely,
Division of Corporation Finance
Office of Technology
cc: Craig D. Linder, Esq.